(1 - 30 von 60
)
BIO International 2024IGES Pharma
pharma.iges.com
One of the panel members is Santoke Naal, Managing Director of IGES UK Pharma Consulting. He will be joined in the discussions by Thomas Bols, Vice ... One of the panel members is Santoke Naal, Managing Director of IGES UK Pharma Consulting. He will be joined in the discussions by Thomas Bols, Vice ...
Merck Serono Launches easypod™ Connect in Europe
www.informazione.it
... responsiveness to treatment3,4,5,6,7,8", added Thomas Bols, Vice President of Corporate Health Policy and Market Access at Merck Serono.
Wanze : Charlotte Rouxhet et Loïc Leroy, les deux nouveaux échevins...
www.dhnet.be
Sans surprise, Loïc Leroy succède à Thomas Bols, comme échevin. En juin, il sera rejoint par Charlotte Rouxhet, qui remplacera Martine Dabée.
Merck Serono Launches easypod' Connect in Europe
www.finanznachrichten.de
GENEVA, October 24, PRNewswire/ -- A new approach to monitoring injection data collected by easypod™ auto-injector in patients receiving a growth...
Un nouvel échevinDH
www.dhnet.be
— Thomas Bols succède à Christophe Lacroix : il sera échevin le 22 septembre À 32 ans, Thomas Bols se prépare à devenir échevin.
EuropaBio Appoints New Chairman & New Members to the Board
www.bionity.com
At its Annual General Assembly, held on June 23rd in Brussels, EuropaBio formally appointed Stephan Tanda, member of the managing board of DSM, as Chair of the...
EuropaBio welcomes new EMEA technical document on biosimilars
www.bionity.com
The Chair of EuropaBio's Biosimilar Working Group Thomas Bols cautioned: "Whilst Europe now has an approval system in place, ...
EuropaBio-Berichte zur “General Assembly”, „NAC- “ und “Healthcare...
www.biodeutschland.org
Die Mitgliederversammlung der EuropaBio am 23. Juni in Brüssel wählte Stephan B. Tanda, Mitglied des Vorstands des Niederländischen Unternehmens Royal...
POLITICO Brussels Influence, presented by Red Flag: Rail stars —...
www.politico.eu
— Thomas Bols is now SVP and managing director for EMEA at the Drug Information Association. **A message from Red Flag Consulting: Hiring ... › newsletter
Intellectual Property: Last chance for Europe's biotech pioneerssciencebusiness.net › news › Intellectual-Property:-L...
sciencebusiness.net
... and whether they can be substituted for the original product is not even raised, notes Thomas Bols, Amgen's Director of Government Affairs in Europe.
More News – Page Politico.euwww.politico.eu › news › page
www.politico.eu
AFTER an eight-year stint with consultancy GPC International in Brussels, Thomas Bols has moved to Amgen Europe to become director of government affairs.
BioSimilars Market Ripe for Expansion
www.genengnews.com
According to Thomas Bols, director of government affairs, Europe, at Amgen (www.amgen.com), “Biosimilars will play a limited role in patient care because in ...
People, July, PMLiVE
www.pmlive.com
... Thomas Bols (Merck Serono) was re-elected chair of the Healthcare Biotechnology Council; Serge Zybach (Syngenta) remains chair of the Agriculture ... Thomas Bols Acumen appoints new strategy director. Thomas Bols will focus on reinforcing Acumen's healthcare practice ... › people,... › archive...
More News – Page POLITICO.eu
www.politico.eu
AFTER an eight-year stint with consultancy GPC International in Brussels, Thomas Bols has moved to Amgen Europe to become director of government affairs. › news › p...
Acumen reinforces its healthcare offer with new Strategy Director |...
pr.euractiv.com
Brussels, 21 February 2018
Acumen strengthens healthcare operations with new strategy director
www.zenopa.com
Acumen Public Affairs has appointed Thomas Bols as its new strategy director to bolster its healthcare practice.
Intellectual Property: Last chance for Europe's biotech ...Science|Business
sciencebusiness.net
... Thomas Bols, Amgen's Director of Government Affairs in Europe. "There should be guidance about what biosimilars are called," said Bols. "Since they are Thomas Bols, Amgen's Director of Government Affairs in Europe. "There should be guidance about what biosimilars are called," said Bols. "Since they are ...
BioSimilars Market Ripe for Expansionwww.genengnews.com › Insights
www.genengnews.com
· According to Thomas Bols, director of government affairs, Europe, at Amgen (www.amgen.com), “Biosimilars will play a limited role in patient ...
Dynamic Global Events Presents the Global Innovation in Patient ...www.investorwire.com › News Articles
www.investorwire.com
· The conference will feature a wide range of distinguished speakers, such as Thomas Bols, Head Of Government And Patient Advocacy, ...
EuropaBio elects Andrea Rappagliosi as its new chairScience Business
sciencebusiness.net
— EuropaBio also elected Thomas Bols, Director Government Affairs, Europe, Amgen, as Chair of the Healthcare Council and Detlef Niese, ...
COVID-19 Likely to Delay Rare Disease and Gene Therapy Trialshlhnews.com › › covid-19-delaying-rar...
hlhnews.com
· ... Thomas Bols, head of ... But for certain activities like manufacturing, you really have to be in your facilities.” Thomas Bols.
EMEA News In Brief (January 11, 2013) - PRovoke Mediawww.provokemedia.com › latest › article › emea-ne...
www.provokemedia.com
· BRUSSELS—FTI Consulting has added Thomas Bols (pictured) as a managing director in its strategic communications practice. Bols will lead the ...
EuropaBio appoints new chairman - Science|Businesssciencebusiness.net › news › EuropaBio-appoints-ne...
sciencebusiness.net
· ... Thomas Bols, Merck Serono, was re-elected chair of the Healthcare Biotechnology Council; Serge Zybach of Syngenta remains as chair of the ...
Merck Serono Launches easypod™ Connect in EuropePR Newswire UK
www.prnewswire.co.uk
— ... responsiveness to treatment3,4,5,6,7,8", added Thomas Bols, Vice President of Corporate Health Policy and Market Access at Merck Serono.
Movers and Shakers | 26 February 2018The Parliament Magazine
www.theparliamentmagazine.eu
— acumen public affairs: Thomas BOLS joined the team as strategy director. In his new role he will be focusing on the company's healthcare ...
POLITICO Brussels Influence, presented by Red Flag: Rail starspolitico.eu
www.politico.eu
— Thomas Bols is now SVP and managing director for EMEA at the Drug Information Association. **A message from Red Flag Consulting: Hiring ...
Panelists Say Personalized Medicine WorksIf Stakeholders ...Bloomberg Law News
news.bloomberglaw.com
— Thomas Bols, chairman of the Health Care Council of EuropaBio and vice president of corporate health policy and market access for EMD Serono ...
Holes “need patching” in EU biosimilar guidance - PharmaTimes
www.pharmatimes.com
— ... the document that need to be addressed, according to Thomas Bols, director of government affairs, Europe, at biotechnology major Amgen. › ho...
EuropaBio's Healthcare Manifesto , en route to 2020www.bionity.com › news › europabios-healthcare-m...
www.bionity.com
· EuropaBio Healthcare Council Chair, Thomas Bols, noted: “Healthcare biotechnology provides patients with new and targeted solutions for a ...
sortiert nach Relevanz / Datum